The visitorslaunched an earlyattackbut the dangerseemed to have passed until arashclearancelanded straight at the feetofEmmanuel Eboue near the right-hand touchline.
GeneSoft used Glaxo data and doctor testimony to convince the FDA that the skin rash was manageable and worth the risk for a drug that can attack pneumonia.